Back

Differences in response to treatment with a sodium channel antagonists in arrhythmic DCM caused by the SCN5A R222Q versus R814W variant

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in arrhythmias and device therapy 7 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joanna Zakrzewska-Koperska

Institute of Cardiology, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
Effect of proactive esophageal cooling during atrial ablation on ejection fraction and post-procedure fluid overload
Mr J. Sherman (St Louis, US)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of atrial fibrillation in diagnosing chronic heart failure: focus on N-terminal Pro-B-type natriuretic peptide fragment in Uzbek patients
Doctor N. Nasirdinov (Andijan, UZ)
Abstract Slides Video
Presentation thumbnail
A novel telemetry patch for monitoring conduction disturbances following early TAVR discharge
Doctor S. Paula (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
CHA2DS2-VASc score and left atrial low voltage area in various thromboembolic risk profiles in atrial fibrillation patients
Doctor S. Xydonas (Athens, GR) Doctor A. Mpatsouli (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Anticoagulation in patients with atrial high-rate episodes: systematic review and meta analysis
Doctor A. Al-Shammari (Baghdad, IQ) Doctor A. Ibrahim (Alexandria, EG)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in arrhythmias and device therapy 7

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome
thumbnail
Congress Presentation
Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.
thumbnail
Congress Presentation
Evaluation of carriers of pathogenic variants in KCNH2 gene

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources